Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains
Ting Pan, Zhongwei Hu, Fengyu Hu, Yiwen Zhang, Bingfeng Liu, Changwen Ke, Qiumin She, Xin He, Xiaoping Tang, Hui Zhang
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakConvalescent plasmaSars virusConvalescenceBiologyMedicineDiseaseInfectious disease (medical specialty)OutbreakPathologySARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies